Literature DB >> 17666098

Maternal anaemia as an indicator for monitoring malaria control in pregnancy in sub-Saharan Africa.

E J Savage1, K Msyamboza, S Gies, U D'Alessandro, B J Brabin.   

Abstract

DESIGN: Malarial anaemia is a major problem in many developing countries and often occurs more frequently in first pregnancies, as primigravidae are more susceptible to Plasmodium falciparum malaria and are at excess risk of malarial anaemia. OBJECTIVE AND METHODS: To analyse the excess risk of anaemia in primigravidae as a potential indicator of malaria control and exposure in pregnant women living in sub-Saharan Africa. The sensitivity, specificity and predictive values for anaemia in first compared with later pregnancies are calculated for 27 studies from malarious and 7 studies from nonmalarious areas.
SETTING: Surveys of pregnancy anaemia reported for highly malarious and nonmalarious areas.
RESULTS: In malarious areas, the weighted odds ratio for excess anaemia (haemoglobin [Hb] <11 g/dl) in primigravidae compared with multigravidae for all studies was 1.34 (95% CI 1.14-1.58). At an Hb cutoff below 8 g/dl, the weighted odds ratio was 1.79 (95% CI 1.52-2.10). In nonmalarious areas, there was no increased risk of anaemia in primigravidae with Hb below 11 g/dl (OR 0.80; 95% CI 0.63-1.90) or below 8 g/dl (OR 0.82, 95% CI 0.51-1.28).
CONCLUSIONS: In view of the consistency of results across highly malarious areas compared with nonmalarious areas, maternal anaemia has the potential to be used for surveillance of malaria control in pregnancy. Based on the analysis, an anaemia nomogram is developed for use as a surveillance indicator in malarious areas in sub-Saharan Africa.

Entities:  

Mesh:

Year:  2007        PMID: 17666098     DOI: 10.1111/j.1471-0528.2007.01420.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  8 in total

1.  Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women.

Authors:  Nana O Wilson; Fatou K Ceesay; Samuel A Obed; Andrew A Adjei; Richard K Gyasi; Patricia Rodney; Yassa Ndjakani; Winston A Anderson; Naomi W Lucchi; Jonathan K Stiles
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

2.  Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.

Authors:  Verner N Orish; Onyekachi S Onyeabor; Johnson N Boampong; Richmond Afoakwah; Ekene Nwaefuna; Samuel Acquah; Adekunle O Sanyaolu; Nnaemeka C Iriemenam
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

3.  Malaria and HIV co-infection and their effect on haemoglobin levels from three health-care institutions in Lagos, southwest Nigeria.

Authors:  A O Sanyaolu; A F Fagbenro-Beyioku; W A Oyibo; O S Badaru; O S Onyeabor; C I Nnaemeka
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

4.  Comparative efficacy of uncontrolled and controlled intermittent preventive treatment during pregnancy (IPTp) with combined use of LLTNs in high resistance area to sulfadoxine-pyrimethamine in Côte d'Ivoire.

Authors:  A Toure Offianan; Louis K Penali; Ma Coulibaly; Nl Tiacoh; Aab Ako; Eg Adji; B Coulibaly; D Koffi; D Sarr; R Jambou; M Kone
Journal:  Infect Drug Resist       Date:  2012-03-12       Impact factor: 4.003

5.  Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest, Nigeria: a cross-sectional study.

Authors:  Stella O Akinleye; Catherine O Falade; Ikeoluwapo O Ajayi
Journal:  BMC Pregnancy Childbirth       Date:  2009-07-09       Impact factor: 3.007

6.  Zinc erythrocyte protoporphyrin as marker of malaria risk in pregnancy - a retrospective cross-sectional and longitudinal study.

Authors:  Edward L Senga; Gibby Koshy; Bernard J Brabin
Journal:  Malar J       Date:  2012-07-30       Impact factor: 2.979

7.  Malaria and gravidity interact to modify maternal haemoglobin concentrations during pregnancy.

Authors:  Smaïla Ouédraogo; Florence Bodeau-Livinec; Valérie Briand; Bich-Tram Huynh; Ghislain K Koura; Manfred M K Accrombessi; Nadine Fievet; Achille Massougbodji; Philippe Deloron; Michel Cot
Journal:  Malar J       Date:  2012-10-22       Impact factor: 2.979

Review 8.  Monitoring and evaluation of malaria in pregnancy - developing a rational basis for control.

Authors:  Bernard J Brabin; Marian Warsame; Marian Wasame; Ulrika Uddenfeldt-Wort; Stephanie Dellicour; Jenny Hill; Sabine Gies
Journal:  Malar J       Date:  2008-12-11       Impact factor: 2.979

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.